Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cervical Plexus Block vs General Anesthesia for Thyroid/Parathyroid Surgery
NCT04051099Unknown
- Sponsor
- Mahidol University
- Start
- Mar 2018
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of bupivacaine hydrochloride 0.75% injection in Benign thyroid tumors and hyperparathyroidism (2 arms), sponsored by Mahidol University. Primary endpoint: Postoperative pain score at rest at 24 hours. Status: unknown.
02
Drugs
bupivacaine hydrochloride 0.75% injection
03
Conditions
Benign thyroid tumorshyperparathyroidism
Beyond the preview
Go deeper on NCT04051099.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04051099.